Preservation of fertility in women undergoing chemotherapy: Current approach and future prospects

Ronit Abir*, Benjamin Fisch, Ahud Raz, Shmuel Nitke, Zion Ben-Rafael

*Corresponding author for this work

Research output: Contribution to journalReview articlepeer-review

46 Scopus citations

Abstract

Purpose: Anticancer treatment causes ovarian failure. Methods: Some hormones may have a protective effect on the ovary. Cryopreservation (freezing) of oocytes has had very limited success, and therefore, currently its use before chemotherapy is not a feasible option. However, cryopreservation of embryos is possible. Another solution is oocyte donation followed by in vitro fertilization (IVF). Results: Ovarian cortical slices containing primordial follicles have been cryopreserved successfully. To restore fertility, cryopreserved-thawed tissue taken from cancer patients before therapy could be replanted after recovery. The possible risk of malignancy restoration could be eliminated by obtaining unilaminar follicles from cryopreserved-thawed tissue and growing them in vitro, followed by routine IVF. Conclusions: Although women who undergo chemotherapy face limited options for fertility preservation, intensive studies in cryopreservation and in vitro maturation of follicles harbor hope for brighter prospects in the future.

Original languageEnglish
Pages (from-to)469-477
Number of pages9
JournalJournal of Assisted Reproduction and Genetics
Volume15
Issue number8
DOIs
StatePublished - 1998
Externally publishedYes

Keywords

  • 'protective' hormonal treatment
  • Chemotherapy
  • Cryopreservation
  • In vitro maturation
  • Primordial follicles

Fingerprint

Dive into the research topics of 'Preservation of fertility in women undergoing chemotherapy: Current approach and future prospects'. Together they form a unique fingerprint.

Cite this